Effect of electroporation-mediated diphtheria toxin A expression on PSA positive human prostate xenograft tumors in SCID mice

Prostate

Volumn 71, Issue 8, 2011, Pages 872-880

  Goepfert, Christine ^a   Gazdhar, Amiq ^b   Frey, Felix J ^a   Frey, Brigitte M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Apoptosis; Gene delivery; Prostate cancer; Stereology; Tumor model

Indexed keywords

ANDROGEN RECEPTOR; DIPHTHERIA TOXIN; DIPHTHERIA TOXIN A; DMRIE C; PROSTATE SPECIFIC ANTIGEN; REAGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CANCER INHIBITION; CANCER TRANSPLANTATION; CELL GROWTH; CONTROLLED STUDY; ELECTROPORATION; GENE DELIVERY SYSTEM; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; SCID MOUSE; STEREOLOGY; SUICIDE GENE; TUMOR BIOPSY; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; APOPTOSIS; CELL LINE, TUMOR; DIPHTHERIA TOXIN; ELECTROPORATION; HUMANS; LIPIDS; MALE; MICE; MICE, SCID; PEPTIDE FRAGMENTS; PLASMIDS; PROMOTER REGIONS, GENETIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; QUATERNARY AMMONIUM COMPOUNDS; RECEPTORS, ANDROGEN; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79953701059     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21303     Document Type: Article

References (49)

1. Vishnu P, Tan WW. Update on options for treatment of metastatic castration-resistant prostate cancer. Onco Targets Ther 2010;3:39-51.
2. Shalev M, Miles BJ, Thompson TC, Ayala G, Butler EB, Aguilar-Cordova E, Kadmon D. Suicide gene therapy for prostate cancer using a replication-deficient adenovirus containing the herpesvirus thymidine kinase gene. World J Urol 2000;18(2):125-129.
3. Wells DJ. Electroporation and ultrasound enhanced non-viral gene delivery in vitro and in vivo. Cell Biol Toxicol 2010; 26(1):21-28.
4. Koreckij TD, Hill C, Azure L, Nguyen H, Kunz LL, Azure A, Corey E, Lange P, Vessella RL. Low dose, alternating electric current inhibits growth of prostate cancer. Prostate 2010;70(5): 529-539.
5. Heller LC, Heller R. In vivo electroporation for gene therapy. Hum Gene Ther 2006;17(9):890-897.
6. Favard C, Dean DS, Rols MP. Electrotransfer as a non viral method of gene delivery. Curr Gene Ther 2007;7(1):67-77. (Pubitemid 46322289)
7. Wells JM, Li LH, Sen A, Jahreis GP, Hui SW. Electroporation-enhanced gene delivery in mammary tumors. Gene Ther 2000; 7(7):541-547. (Pubitemid 30175556)
8. Lucas ML, Heller L, Coppola D, Heller R. IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. Mol Ther 2002; 5(6):668-675. (Pubitemid 34624563)
9. Cemazar M, Golzio M, Sersa G, Hojman P, Kranjc S, Mesojednik S, Rols MP, Teissie J. Control by pulse parameters of DNA electrotransfer into solid tumors in mice. Gene Ther 2009;16(5): 635-644.
10. Hofmann GA, Dev SB, Dimmer S, Nanda GS. Electroporation therapy: A new approach for the treatment of head and neck cancer. IEEE T Bio Med Eng 1999;46(6):752-759. (Pubitemid 29245066)
11. Mikata K, Uemura H, Ohuchi H, Ohta S, Nagashima Y, Kubota Y. Inhibition of growth of human prostate cancer xenograft by transfection of p53 gene: Gene transfer by electroporation. Mol Cancer Ther 2002;1(4):247-252.
12. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, Wenz M, Northrop JP, Ringold GM, Danielsen M. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987;84(21):7413-7417.
13. Suzuki T, Tadakuma T, Kunitomi M, Takayama E, Sato M, Asano T, Nakamura H, Hayakawa M. Liposome-mediated gene therapy using HSV-TK/ganciclovir under the control of human PSA promoter in prostate cancer cells. Urol Int 2001;67(3):216-223. (Pubitemid 34701821)
14. Kunitomi M, Takayama E, Suzuki S, Yasuda T, Tsutsui K, Nagaike K, Hiroi S, Tadakuma T. Selective inhibition of hepatoma cells using diphtheria toxin A under the control of the promoter/enhancer region of the human alpha-fetoprotein gene. Jpn J Cancer Res 2000;91(3):343-350. (Pubitemid 30198176)
15. Ochiya T, Takahama Y, Baba-Toriyama H, Tsukamoto M, Yasuda Y, Kikuchi H, Terada M. Evaluation of cationic liposome suitable for gene transfer into pregnant animals. Biochem Bioph Res Commun 1999;258(2):358-365. (Pubitemid 29287056)
16. Maxwell IH, Maxwell F, Glode LM. Regulated expression of a diphtheria-toxin a-chain gene transfected into human-cells - Possible strategy for inducing cancer cell suicide. Cancer Res 1986;46(9):4660-4664. (Pubitemid 16000341)
17. Rodriguez R, Lim HY, Bartkowski LM, Simons JW. Identification of diphtheria toxin via screening as a potent cell cycle and p53-independent cytotoxin for human prostate cancer therapeutics. Prostate 1998;34(4):259-269. (Pubitemid 28149870)
18. Massuda ES, Dunphy EJ, Redman RA, Schreiber JJ, Nauta LE, Barr FG, Maxwell IH, Cripe TP. Regulated expression of the diphtheria toxin A chain by a tumor-specific chimeric transcription factor results in selective toxicity for alveolar rhabdomyosarcoma cells. Proc Natl Acad Sci USA 1997;94(26): 14701-14706. (Pubitemid 28041437)
19. Rustamzadeh E, Hall WA, Todhunter DA, Low WC, Liu H, Panoskaltsis-Mortari A, Vallera DA. Intracranial therapy of glioblastoma with the fusion protein DTIL13 in immunodeficient mice. Int J Cancer 2006;118(10):2594-2601.
20. Mizrahi A, Czerniak A, Levy T, Amiur S, Gallula J, Matouk I, Abu-lail R, Sorin V, Birman T, de Groot N, Hochberg A, Ohana P. Development of targeted therapy for ovarian cancer mediated by a plasmid expressing diphtheria toxin under the control of H19 regulatory sequences. J Transl Med 2009;7:69.
21. Anderson DG, Peng W, Akinc A, Hossain N, Kohn A, Padera R, Langer R, Sawicki JA. A polymer library approach to suicide gene therapy for cancer. Proc Natl Acad Sci USA 2004;101(45): 16028-16033. (Pubitemid 39507921)
22. Li Y, McCadden J, Ferrer F, Kruszewski M, Carducci M, Simons J, Rodriguez R. Prostate-specific expression of the diphtheria toxin A chain (DT-A): Studies of inducibility and specificity of expression of prostate-specific antigen promoter-driven DT-A adenoviral-mediated gene transfer. Cancer Res 2002;62(9): 2576-2582. (Pubitemid 34462737)
23. Schuur ER, Henderson GA, Kmetec LA, Miller JD, Lamparski HG, Henderson DR. Prostate-specific antigen expression is regulated by an upstream enhancer. J Biol Chem 1996;271(12): 7043-7051. (Pubitemid 26104139)
24. Koivisto PA, Helin HJ. Androgen receptor gene amplification increases tissue PSA protein expression in hormone-refractory prostate carcinoma. J Pathol 1999;189(2):219-223. (Pubitemid 29448916)
25. Park HS, Cheon J, Cho HY, Ko YH, Bae JH, Moon DG, Kim JJ. In vivo characterization of a prostate-specific antigen promoter-based suicide gene therapy for the treatment of benign prostatic hyperplasia. Gene Ther 2003;10(13):1129-1134.
26. Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, Ozen M, Pathak S, Chung LW. LNCaP progression model of human prostate cancer: Androgen- independence and osseous metastasis. Prostate 2000;44(2):91-103 [101;144 (102)].
27. van der Poel HG, McCadden J, Verhaegh GW, Kruszewski M, Ferrer F, Schalken JA, Carducci M, Rodriguez R. A novel method for the determination of basal gene expression of tissue-specific promoters: An analysis of prostate-specific promoters. Cancer Gene Ther 2001;8(12):927-935. (Pubitemid 33140311)
28. Huang X, Bennett M, Thorpe PE. Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen. Prostate 2004; 61(1):1-11. (Pubitemid 39095691)
29. Zbaeren J, Zbaeren-Colbourn D, Haeberli A. High-resolution immunohistochemistry on improved glycol methacrylate-resin sections. J Histotechnol 2007;30(1):27-33.
30. Gundersen HJ, Jensen EB. The efficiency of systematic sampling in stereology and its prediction. J Microsc 1987;147(Pt 3):229-263.
31. Vanhecke D, Studer D, Ochs M. Reprint of "Stereology meets electron tomography: Towards quantitative 3D electron microscopy" J Struct Biol 2007;159:443-450
32. [J Struct Biol 2008;161 (3):314-321].
33. Morimoto H, Bonavida B. Diphtheria toxin- and Pseudomonas A toxin-mediated apoptosis. ADP ribosylation of elongation factor-2 is required for DNA fragmentation and cell lysis and synergy with tumor necrosis factor-alpha. J Immunol 1992; 149(6):2089-2094.
34. Ahmad S, Casey G, Sweeney P, Tangney M, O'Sullivan GC. Optimised electroporation mediated DNA vaccination for treatment of prostate cancer. Genet Vaccines Ther 2010;8(1):1.
35. Dona M, Sandri M, Rossini K, Dell'Aica I, Podhorska-Okolow M, Carraro U. Functional in vivo gene transfer into the myofibers of adult skeletal muscle. Biochem Biophys Res Commun 2003; 312(4):1132-1138. (Pubitemid 37490933)
36. Heller LC, Jaroszeski MJ, Coppola D, Heller R. Comparison of electrically mediated and liposome-complexed plasmid DNA delivery to the skin. Genet Vaccines Ther 2008;6:16.
37. Yamaizumi M, Mekada E, Uchida T, Okada Y. One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell 1978;15(1):245-250. (Pubitemid 9027527)
38. Zheng JY, Chen D, Chan J, Yu D, Ko E, Pang S. Regression of prostate cancer xenografts by a lentiviral vector specifically expressing diphtheria toxin A. Cancer Gene Ther 2003;10(10): 764-770. (Pubitemid 37243797)
39. Lupold SE, Rodriguez R. Adenoviral gene therapy, radiation, and prostate cancer. Rev Urol 2005;7(4):193-202.
40. Huang YH, Zugates GT, Peng W, Holtz D, Dunton C, Green JJ, Hossain N, Chernick MR, Padera RF, Jr., Langer R, Anderson DG, Sawicki JA. Nanoparticle-delivered suicide gene therapy effectively reduces ovarian tumor burden in mice. Cancer Res 2009;69(15):6184-6191.
41. Pang S, Dannull J, Kaboo R, Xie Y, Tso CL, Michel K, deKernion JB, Belldegrun AS. Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen. Cancer Res 1997;57(3):495-499.
42. Lee SE, Jin RJ, Lee SG, Yoon SJ, Park MS, Heo DS, Choi H. Development of a new plasmid vector with PSA-promoter and enhancer expressing tissue-specificity in prostate carcinoma cell lines. Anticancer Res 2000;20(1A):417-422. (Pubitemid 30189788)
43. Peng W, Anderson DG, Bao Y, Padera RF, Jr., Langer R, Sawicki JA. Nanoparticulate delivery of suicideDNAto murine prostate and prostate tumors. Prostate 2007;67(8):855-862. (Pubitemid 46828939)
44. Peng W, Chen J, Huang YH, Sawicki JA. Tightly-regulated suicide gene expression kills PSA-expressing prostate tumor cells. Gene Ther 2005;12(21):1573-1580. (Pubitemid 41541775)
45. Kaiser S, Toborek M. Liposome-mediated high-efficiency transfection of human endothelial cells. J Vasc Res 2001;38(2):133-143. (Pubitemid 32337215)
46. Glazyrin AL, Kan-Mitchell J, Mitchell ML. Analysis of in vitro immunization: Generation of cytotoxic T-lymphocytes against allogeneic melanoma cells with tumor lysate-loaded or tumor RNA-transfected antigen-presenting cells. Cancer Immunol Immunother 2003;52(3):171-178. (Pubitemid 36384717)
47. Heller L, Jaroszeski MJ, Coppola D, Pottinger C, Gilbert R, Heller R. Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo. Gene Ther 2000;7(10):826-829. (Pubitemid 30303578)
48. Gazdhar A, Bilici M, Pierog J, Ayuni EL, Gugger M, Wetterwald A, Cecchini M, Schmid RA. In vivo electroporation and ubiquitin promoter - Aprotocol for sustained gene expression in the lung. J Gene Med 2006;8(7):910-918.
49. Shibata MA, Morimoto J, Otsuki Y. Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation. Cancer Gene Ther 2002;9(1):16-27. (Pubitemid 34052850)